Loading clinical trials...
Loading clinical trials...
The goal of this clinical trial is to find out at which lower limit for saturation (amount of oxygen in the blood) we can best give extra oxygen to children that have been admitted for shortness of breath. We hope to accomplish a shorter period of illness for these children and that they can be discharged home earlier. Participants will receive supplemental oxygen if their blood oxygen levels are below 88% or below 92%. After admission, (parents of) participating children will fill out questionnaires. We will compare the two groups on their hospitalization duration and recovery. In other words, is it better to maintain a lower limit of 88% saturation or a lower limit of 92% in children admitted for shortness of breath?
Age
0 - 12 years
Sex
ALL
Healthy Volunteers
No
Spaarne Gasthuis
Haarlem, North Holland, Netherlands
Canisius Wilhelmina Ziekenhuis
Arnhem, Netherlands
Rijnstate Ziekenhuis
Arnhem, Netherlands
Amphia Ziekenhuis
Breda, Netherlands
Martini Ziekenhuis
Groningen, Netherlands
Tergooi Ziekenhuis
Hilversum, Netherlands
St Antonius Ziekenhuis
Nieuwegein, Netherlands
Franciscus Gasthuis en Vlietland
Rotterdam, Netherlands
Isala Klinieken
Zwolle, Netherlands
Start Date
September 4, 2023
Primary Completion Date
December 31, 2025
Completion Date
December 31, 2025
Last Updated
October 16, 2024
560
ESTIMATED participants
Oxygen saturation threshold
OTHER
Lead Sponsor
Spaarne Gasthuis
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06321133